Firms ally to develop plant-based drugs

02/20/2013 | Genetic Engineering & Biotechnology News

Caliber Biotherapeutics and iBio agreed to jointly develop and produce recombinant plant-based biopharmaceuticals using Caliber's plant-based production expertise and the iBioLaunch platform. The partners will initially work on a monoclonal antibody for cancer. iBio will get license and milestone fees and sales royalties on products arising from the collaboration.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC